Literature DB >> 6247161

beta-Adrenoceptor studies. 6. Further investigations on the hybrid nature of the rat adipocyte beta-adrenoceptor.

J de Vente, A Bast, L Van Bree, J Zaagsma.   

Abstract

The nature of the rat adipocyte beta-adrenoceptor was studied in further detail using a selected series of tolamol-type beta-adrenoceptor antagonists. Isoprenaline antagonism by these compounds was evaluated on adipocytes, right atrium, left atrium and left hemidiaphragm of the rat. Adipocyte pA2 values were corrected for binding to bovine serum albumin determined separately for each antagonist. A strong correlation between adipocyte and diaphragm pA2 values was found with those antagonists which had an identical N-substituent but a different substitution pattern in the phenoxypropanolamine ring. This relationship was absent with those compounds which had the same 2-methylphenoxypropanolamine moiety but a different N-substituent. With the latter antagonists, however, adipocyte pA2 values correlated significantly with the two cardiac pA2 values. These results support the idea that the interaction site of the rat adipocyte beta-adrenoceptor for the aromatic moiety of arylethanolamines and aryloxypropanolamines has beta 2-characteristics whereas the alkanolamine side-chain interaction site has a beta 1-nature. Finally, it was ascertained that the apparently dualistic (beta 1 and beta 2) character of the rat adipocyte adrenoceptor is not due to the presence of both a beta 1- and a beta 2-receptor population on the fat cell plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6247161     DOI: 10.1016/0014-2999(80)90118-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

1.  Effect of BRL-35135 on LTB4-induced guinea pig eosinophil chemotaxis.

Authors:  T Sugasawa; S Morooka
Journal:  Agents Actions       Date:  1992-11

Review 2.  Biotechnology of beta-adrenergic receptors.

Authors:  A D Strosberg
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

3.  Direct evidence for the atypical nature of functional beta-adrenoceptors in rat adipocytes.

Authors:  C Hollenga; J Zaagsma
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

4.  Atypical characteristics of the beta-adrenoceptor mediating cyclic AMP generation and lipolysis in the rat adipocyte.

Authors:  D Bojanic; J D Jansen; S R Nahorski; J Zaagsma
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

5.  The beta-adrenoceptor-adenylate cyclase complex. From model to biochemical reality.

Authors:  A P Ijzerman; H Timmerman
Journal:  Pharm Weekbl Sci       Date:  1986-08-22

Review 6.  Beta-adrenoceptor blocking agents and lipolysis.

Authors:  H H Harms; J De Vente; J Zaagsma
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

7.  Cardiac effects of the beta 3-adrenoceptor agonist BRL35135 in man.

Authors:  N M Wheeldon; D G McDevitt; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1994-04       Impact factor: 4.335

8.  Proceedings of the British Pharmacological Society. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1984-03       Impact factor: 8.739

9.  Acute change in the cyclic AMP content of rat mammary acini in vitro. Influence of physiological and pharmacological agents.

Authors:  R A Clegg; I Mullaney
Journal:  Biochem J       Date:  1985-08-15       Impact factor: 3.857

Review 10.  The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from beta3-adrenoceptor agonists.

Authors:  Jonathan R S Arch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-09       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.